Spotlight: Intec enrolls patients in PhIII trial

An MIT team has invented a device that makes a variety of drugs "on demand." "Think of this as the emergency backup for pharmaceutical manufacturing," MIT chemical engineering professor Allan Myerson said in a news release. "The purpose is not to replace traditional manufacturing; it's to provide an alternative for these special situations." More

> Intec Pharma enrolled its first patient in the Phase III trial of its drug delivering Accordion Pill for the treatment of Parkinson's Disease. More

> Sweden's Moberg Pharma has divested Jointflex, Fergon and Vanquish brands to Strides Pharma for $10.4 million. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.